RFG - Bristol Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
3,200
+3
+0.1% +$262 0.07% 146
2026
Q1
$272K Buy
3,197
+4
+0.1% +$357 0.07% 153
2025
Q4
$252K Buy
3,193
+3
+0.1% +$235 0.07% 158
2025
Q3
$255K Buy
3,190
+4
+0.1% +$341 0.07% 161
2025
Q2
$290K Buy
3,186
+3
+0.1% +$274 0.09% 148
2025
Q1
$298K Buy
3,183
+3
+0.1% +$269 0.1% 138
2024
Q4
$289K Buy
+3,180
New +$303K 0.09% 127

Other funds holding CL

RFG - Bristol Wealth Advisors's CL Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors increased its Colgate-Palmolive (CL) stake by 0.09% in Q2 2026, buying an estimated $262 and bringing the position to 3,200 shares worth $293K. The position accounts for 0.07% of the portfolio, ranked #146.

RFG - Bristol Wealth Advisors first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $298K in Q1 2025. 684 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • RFG - Bristol Wealth Advisors held 3,200 shares of Colgate-Palmolive worth $293K as of Q2 2026.
  • RFG - Bristol Wealth Advisors bought 3 Colgate-Palmolive shares in Q2 2026, an estimated $262.
  • Colgate-Palmolive made up 0.07% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #146 holding.
  • RFG - Bristol Wealth Advisors first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • RFG - Bristol Wealth Advisors's Colgate-Palmolive position peaked at $298K in Q1 2025.
  • 684 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.